# OnCo record etx-19477 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/etx-19477/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "etx-19477" ;
  schema:name "ETX-19477"@en ;
  schema:description "ETX-19477 is an experimental small molecule from 858 Therapeutics, in phase 1 trials for advanced solid tumours, BRCA-mutated platinum-resistant ovarian cancer and BRCA-mutated HR-positive, HER2-negative unresectable or metastatic breast cancer."@en ;
  schema:url <https://onco.cc/drugs/etx-19477/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.8five8tx.com/>, <https://8five8tx.com/news/>, <https://8five8tx.com/news/>, <https://clinicaltrials.gov/api/v2/studies/NCT06395519>, <https://clinicaltrials.gov/search?intr=ETX-19477> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule (oral)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/parg/> ;
  onco:companies <https://onco.cc/companies/858-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06395519/> .